Display options
Share it on

Pediatr Neurol Briefs. 2019 Dec 31;33:5. doi: 10.15844/pedneurbriefs-33-5.

Spinal Muscular Atrophy Diagnosed by Newborn Screening.

Pediatric neurology briefs

Matias Lopez-Chacon, Amber N Buehner, Vamshi K Rao

Affiliations

  1. Division of Neurology, Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago, IL.
  2. Department of Pediatrics and Neurology, Northwestern University Feinberg School of Medicine, Chicago, IL.

PMID: 31929716 PMCID: PMC6942550 DOI: 10.15844/pedneurbriefs-33-5

Abstract

A panel of experts representing academic centers, family foundations and pharmaceutical industry came together to formulate a treatment algorithm for infants diagnosed via newborn screening (NBS) with Spinal muscular atrophy (SMA).

Copyright: © 2019 The Author(s).

Keywords: Guidelines; Newborn Screening; Spinal Muscular Atrophy

Conflict of interest statement

The authors have declared that no competing interests exist.

References

  1. Pediatr Neurol. 2015 Oct;53(4):293-300 - PubMed
  2. N Engl J Med. 2017 Nov 2;377(18):1713-1722 - PubMed
  3. N Engl J Med. 2017 Nov 2;377(18):1723-1732 - PubMed
  4. J Neuromuscul Dis. 2018;5(2):145-158 - PubMed

Publication Types